Literature DB >> 9696823

Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.

D Missé1, M Cerutti, I Schmidt, A Jansen, G Devauchelle, F Jansen, F Veas.   

Abstract

To evaluate conserved structures of the surface gp120 subunit (SU) of the human immunodeficiency virus type 1 (HIV-1) envelope in gp120-cell interactions, we designed and produced an HIV-1 IIIB (HXB2R) gp120 carrying a deletion of amino acids E61 to S85. This sequence corresponds to a highly conserved predicted amphipathic alpha-helical structure located in the gp120 C1 region. The resultant soluble mutant with a deleted alpha helix 1 (gp120 DeltaalphaHX1) exhibited a strong interaction with CXCR4, although CD4 binding was undetectable. The former interaction was specific since it inhibited the binding of the anti-CXCR4 monoclonal antibody (12G5), as well as SDF1alpha, the natural ligand of CXCR4. Additionally, the mutant gp120 was able to bind to CXCR4(+)/CD4(-) cells but not to CXCR4(-)/CD4(-) cells. Although efficiently expressed on cell surface, HIV envelope harboring the deleted gp120 DeltaalphaHX1 associated with wild-type transmembrane gp41 was unable to induce cell-to-cell fusion with HeLa CD4(+) cells. Nevertheless, the soluble gp120 DeltaalphaHX1 efficiently inhibited a single round of HIV-1 LAI infection in HeLa P4 cells, with a 50% inhibitory concentration of 100 nM. Our data demonstrate that interaction with the CXCR4 coreceptor was maintained in a SUgp120 HIV envelope lacking alphaHX1. Moreover, in the absence of CD4 binding, the interaction of gp120 DeltaalphaHX1 with CXCR4 was sufficient to inhibit HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696823      PMCID: PMC109951     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Prevention of HIV infection by passive immunization with HIV immunoglobulin.

Authors:  A M Prince; H Reesink; D Pascual; B Horowitz; I Hewlett; K K Murthy; K E Cobb; J W Eichberg
Journal:  AIDS Res Hum Retroviruses       Date:  1991-12       Impact factor: 2.205

2.  Identification of a major co-receptor for primary isolates of HIV-1.

Authors:  H Deng; R Liu; W Ellmeier; S Choe; D Unutmaz; M Burkhart; P Di Marzio; S Marmon; R E Sutton; C M Hill; C B Davis; S C Peiper; T J Schall; D R Littman; N R Landau
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

3.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

4.  The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.

Authors:  H Choe; M Farzan; Y Sun; N Sullivan; B Rollins; P D Ponath; L Wu; C R Mackay; G LaRosa; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

5.  HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Authors:  Y Feng; C C Broder; P E Kennedy; E A Berger
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

6.  A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

Authors:  B J Doranz; J Rucker; Y Yi; R J Smyth; M Samson; S C Peiper; M Parmentier; R G Collman; R W Doms
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

7.  TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions.

Authors:  C Denesvre; C Carrington; A Corbin; Y Takeuchi; F L Cosset; T Schulz; M Sitbon; P Sonigo
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

Authors:  S S Hwang; T J Boyle; H K Lyerly; B R Cullen
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.

Authors:  B Chesebro; K Wehrly; J Nishio; S Perryman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region.

Authors:  S R Pollard; M D Rosa; J J Rosa; D C Wiley
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  10 in total

1.  Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.

Authors:  K Salzwedel; E D Smith; B Dey; E A Berger
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  A high-throughput fluorescence polarization assay specific to the CD4 binding site of HIV-1 glycoproteins based on a fluorescein-labelled CD4 mimic.

Authors:  François Stricher; Loïc Martin; Philippe Barthe; Vivian Pogenberg; Alain Mechulam; André Menez; Christian Roumestand; Francisco Veas; Catherine Royer; Claudio Vita
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

3.  Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.

Authors:  Alain Mechulam; Martine Cerutti; Martine Pugnière; Dorothée Missé; Johanna Gajardo; Françoise Roquet; James Robinson; Francisco Veas
Journal:  J Mol Med (Berl)       Date:  2005-05-19       Impact factor: 4.599

4.  Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.

Authors:  C C LaBranche; T L Hoffman; J Romano; B S Haggarty; T G Edwards; T J Matthews; R W Doms; J A Hoxie
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Identification of CXCR4 domains that support coreceptor and chemokine receptor functions.

Authors:  B J Doranz; M J Orsini; J D Turner; T L Hoffman; J F Berson; J A Hoxie; S C Peiper; L F Brass; R W Doms
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.

Authors:  A Borsetti; C Parolin; B Ridolfi; L Sernicola; A Geraci; B Ensoli; F Titti
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Peptide mimic of the HIV envelope gp120-gp41 interface.

Authors:  Sunghwan Kim; Hong-Bo Pang; Michael S Kay
Journal:  J Mol Biol       Date:  2007-12-07       Impact factor: 5.469

8.  A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptide.

Authors:  Grégoire Martin; Yide Sun; Bernadette Heyd; Olivier Combes; Jeffrey B Ulmer; Anne Descours; Susan W Barnett; Indresh K Srivastava; Loïc Martin
Journal:  Virology       Date:  2008-10-02       Impact factor: 3.616

9.  Isolation and functional characterization of a new shrimp ovarian peritrophin with antimicrobial activity from Fenneropenaeus merguiensis.

Authors:  Wiriya Loongyai; Jean-Christophe Avarre; Martine Cerutti; Esther Lubzens; Wilaiwan Chotigeat
Journal:  Mar Biotechnol (NY)       Date:  2007-07-21       Impact factor: 3.619

10.  The HIV-1 Gp120/CXCR4 axis promotes CCR7 ligand-dependent CD4 T cell migration: CCR7 homo- and CCR7/CXCR4 hetero-oligomer formation as a possible mechanism for up-regulation of functional CCR7.

Authors:  Haruko Hayasaka; Daichi Kobayashi; Hiromi Yoshimura; Emi E Nakayama; Tatsuo Shioda; Masayuki Miyasaka
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.